Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities

Fig. 5

The survival outcomes of each subgroup. (A) OS in hematologic malignancy-related genetic abnormalities. (B) OS in lung cancer surgical history. (C) OS in staging subgroups of lung cancer among multiple primary cancers. (D) OS in PS score of lung cancer. (E) OS in pathological subgroups of lung cancer. (F) OS in subgroups with different time intervals between two tumors

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us